Metformin may improve outcomes in patients with non-small cell lung cancer (NSCLC) who are overweight or obese, according to a study published in the Journal of the National Cancer Institute. - ideatrash - news

Delete Set public Set private

940 shaares

940 shaares

Filters

Links per page

20 50 100

Metformin may improve outcomes in patients with non-small cell lung cancer (NSCLC) who are overweight or obese, according to a study published in the Journal of the National Cancer Institute.

research · Metformin · cancer

November 21, 2024 at 12:17:09 AM EST * · permalink

·

https://www.cancertherapyadvisor.com/news/metformin-nsclc-overweight-obese/

Filters

Links per page

20 50 100